KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Globus Medical (GMED) Shares Outstanding (2016 - 2026)

Globus Medical filings provide 15 years of Shares Outstanding readings, the most recent being $112.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding fell 2.06% to $112.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $112.6 million, a 2.06% decrease, with the full-year FY2025 number at $112.6 million, down 2.06% from a year prior.
  • Shares Outstanding hit $22.4 million in Q4 2025 for Globus Medical, down from $112.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $118.2 million in Q3 2023 to a low of $22.4 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $78.0 million (2021), compared with a mean of $65.7 million.
  • The widest YoY moves for Shares Outstanding: up 403.47% in 2024, down 81.02% in 2024.
  • Globus Medical's Shares Outstanding stood at $22.4 million in 2021, then skyrocketed by 246.69% to $77.8 million in 2022, then surged by 46.48% to $113.9 million in 2023, then increased by 0.95% to $115.0 million in 2024, then dropped by 2.06% to $112.6 million in 2025.
  • The last three reported values for Shares Outstanding were $112.6 million (Q4 2025), $112.2 million (Q3 2025), and $22.4 million (Q2 2025) per Business Quant data.